In this Mendelian randomization study, having Alzheimer’s disease was associated with lower branched-chain amino acid levels, but there was no evidence for a causative effect of genetically predicted branched-chain amino acid levels on Alzheimer’s disease risk.
This Study Summary was published on June 2, 2023.
